COLCHICINE | A204711 | AMNEAL PHARMACEUTICALS
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Takeda Pharmaceuticals USA Inc. v. Amneal Pharmaceuticals LLC 5 patentsANDA 204711colchicine | D. Del. | 2013-10-21 | Terminated 2016-05-03 | — |
| D. Del. | 2013-03-28 | Terminated 2014-09-22 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.1287
per ea
Lowest NADAC/Unit
$0.1287
per ea
Brand NDCs
0
Generic NDCs
3
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 50268018715COLCHICINE 0.6 MG TABLET | $0.1287 | EA | Generic | — | 2026-06-17 |
| 65162071003COLCHICINE 0.6 MG TABLET | $0.1287 | EA | Generic | — | 2026-06-17 |
| 65162071009COLCHICINE 0.6 MG TABLET | $0.1287 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.